Variable | Full analysis set | Per-protocol analysis set | ||||||
---|---|---|---|---|---|---|---|---|
 | Trial n=175 | Control n=175 | t/Z | P | Trial n=155 | Control n=151 | t/Z | P |
Frequency (times) | ||||||||
Month 0 | 3.26 ± 2.27 | 2.94 ± 2.05 | 1.378 | 0.169 | 3.32 ± 2.31 | 2.95 ± 1.91 | 1.523 | 0.129 |
Month 6 | 1.02 ± 1.51 | 1.71 ± 2.14 | −3.484 | 0.001 | 0.97 ± 1.26 | 1.48 ± 1.81 | −2.888 | 0.004 |
Month 18 | 0.49 ± 0.77 | 1.09 ± 1.15 | −5.689 | 0.000 | 0.54 ± 0.75 | 1.01 ± 0.98 | −4.798 | 0.000 |
Average frequency | 1.01 ± 1.26 | 1.95 ± 1.88 | −5.509 | 0.000 | 1.02 ± 1.08 | 1.76 ± 1.47 | −4.963 | 0.000 |
Frequency (constituent ratio) | ||||||||
Have exacerbation | 101 | 136 | 18.5857 | 0.000 | 92 | 121 | 15.6084 | 0.000 |
None exacerbation | 76 | 37 | 63 | 30 | ||||
Duration(days) | ||||||||
Average duration | 4.20 ± 5.20 | 6.22 ± 5.15 | −3.653 | 0.000 | 4.39 ± 5.24 | 6.37 ± 5.19 | −3.323 | 0.001 |